QUALITY OF LIFE AND CLINICAL AND FUNCTIONAL STATES IN PATIENTS WITH ANGINA PECTORIS AND LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN THE PRESENCE OF CHRONIC HEART FAILURE

Download full text PDF
Issue: 
3
Year: 
2016

G. Khairutdinova, Professor G. Babushkina, MD City Clinical Hospital Thirteen, Ufa

Incorporation of ivabradine at 12 weeks of combination therapy of patients with stable angina concurrent with left ventricular diastolic dysfunction and an ejection fraction of >50% enhances exercise tolerance, alleviates symptoms, and improves quality of life to achieve target heart rate.

Keywords: 
cardiology
chronic heart failure
heart rate
6-minute walk test
Clinical Assessment Scale
quality of life
ivabradine
bisoprolol



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Skvortsov A.A., Mareev V.Ju., Orlova Ja.A. i dr. Vlijanie dlitel'noj terapii spironolaktonom na parametry sutochnoj variabel'nosti ritma serdtsa i zheludochkovye aritmii u bol'nyh umerennoj i tjazheloj HSN, nahodjaschihsja na optimal'noj terapii // Kardiologija. – 2008; 48 (2): 62–74.
  2. Fomin I.V. Epidemiologija hronicheskoj serdechnoj nedostatochnosti v Rossijskoj Federatsii. Hronicheskaja serdechnaja nedostatochnost' // M.: GEOTAR-Media, 2010; s. 7–77.
  3. Belenkov Ju.N., Oganov R.G., Shljahto E.V. i dr. Soglasovannoe mnenie ekspertov Obschestva spetsialistov po serdechnoj nedostatochnosti. Rezul'taty issledovanija SHIFT i rekomendatsii po vkljucheniju Koraksana v shemu lechenija patsientov s HSN i sinusovym ritmom // Serdechnaja nedostatochnost'. – 2011; 12 (64).
  4. Perepech N.B. Zachem nado umen'shat' chastotu serdechnyh sokraschenij u bol'nyh hronicheskoj serdechnoj nedostatochnost'ju? // Meditsinskij sovet. – 2013; 9: 108–16.
  5. Pocock S., Wang D., Pfefer M. et al. Predictors of mortality and morbidity in patients with chronic heart failure // Eur. Heart J. – 2006; 27 (1): 65–75.
  6. Flannery G., Gehrig Mills R., Billah B. et al. Analysis of randomized controlled trials on the efect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving betablockers // Am. J. Cardiol. – 2008; 101 (6): 865–9.
  7. Bohm M., Swedberg K., Komajda M. et al. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial // Lancet. – 2010; 376 (9744): 886–94.
  8. Issledovanie BEAUTIFUL – shag vpered v lechenii ishemicheskoj bolezni serdtsa // Med. vestn. – 2008; 30: 3–8.
  9. Voronkov L.G., Paraschenjuk L.P. Kachestvo zhizni pri hronicheskoj serdechnoj nedostatochnosti: aktual'nye aspekty // Sertseva nedostatnіst'. – 2010; 2: 12–6.